HIV/AIDS Topics Highlights from the National HIV Prevention Conference
- Details
- Category: HIV Prevention
- Published on Wednesday, 17 August 2011 00:00
- Written by Liz Highleyman
The annual National HIV Prevention Conference, organized by the U.S. Centers for Disease Control and Prevention (CDC) -- is taking place this week (August 14-17) in Atlanta.
The meeting brings together more than 3000 public health officials, medical providers, and HIV/AIDS community leaders and advocates to share the latest research in the field of prevention and to discuss strategies for reducing the number of new HIV infections in the U.S.
Large Vaccine Study Will Look at HIV Prevention as well as Disease Progression
- Details
- Category: HIV Vaccines
- Published on Tuesday, 09 August 2011 00:00
- Written by NIAID
A large ongoing HIV vaccine study will now test whether a prime-boost candidate can prevent infection as well as lower viral load among people infected, based on the promising protective effect seen so far, the National Institutes of Allergy and Infectious Diseases (NIAID) announced.
IAS 2011: Final iPrEX Analysis Confirms PrEP Effectiveness for Gay Men
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 29 July 2011 00:00
- Written by Paul Dalton
Pre-exposure prophylaxis (PrEP) was shown to be highly effective for men and transgender women who have sex with men in a completed analysis of the large iPrEx trial presented at IAS 2011, but the prevention effect was blunted by low levels of adherence.
IAS 2011: Hormonal Contraceptive Use Increases Women’s Risk of Acquiring and Transmitting HIV
- Details
- Category: HIV Sexual Transmission
- Published on Friday, 05 August 2011 00:00
- Written by Roger Pebody
A two-year, seven-country study has concluded that women using hormonal contraceptives, particularly injectable forms, are at a greater risk both of acquiring HIV themselves and of passing it on to a male sexual partner.
IAS 2011: iPrEx Shows PrEP is Durable [VIDEO]
- Details
- Category: HIV Prevention
- Published on Friday, 29 July 2011 00:00
- Written by Video
The effectiveness of biomedical approaches to prevent HIV infection was a key theme of the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011), held July 17-20, 2011, in Rome.
Among the major studies presented, Robert Grant from the Gladstone Institute of the University of California at San Francisco described final data from the iPrEx trial, which showed that pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine (Truvada) reduced new HIV infections by 42% overall, and by more than 90% among people who demonstrated good adherence.
Web Design and Development by